Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

HIV Adherence Bottle Intervention Trial

Not Applicable

Completed

Conditions: Adherence, Medication
HIV-1-infection

Interventions: Behavioral: Routine adherence counseling
Device: Adheretech "smart bottle"

First Posted Date: 2018-12-11

Last Posted Date: 2019-10-02

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 63

Registration Number: NCT03772327

Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis

Early Phase 1

Withdrawn

Conditions: Chronic Sinusitis
Rhinosinusitis

Interventions: Device: Propel 'implant'
Drug: Triamcinolone
Device: Nasopore

First Posted Date: 2018-11-02

Last Posted Date: 2020-05-28

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03729310

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Expanding HIV Testing Among Uganda Adults Who Utilize Traditional Healers

Not Applicable

Completed

Conditions: HIV/AIDS
Health Behaviors

Interventions: Behavioral: HIV testing at traditional healer practices

First Posted Date: 2018-10-25

Last Posted Date: 2021-03-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 500

Registration Number: NCT03718871

Locations: 🇺🇬
Mbarara University of Science and Technology, Mbarara, Uganda

Reward Function and Therapy for Late-Life Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Behavioral: Engage Therapy
Behavioral: Supportive Therapy

First Posted Date: 2018-09-28

Last Posted Date: 2024-11-14

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 65

Registration Number: NCT03688139

Locations: 🇺🇸
Weill Cornell Medicine, White Plains, New York, United States

Comparison of Global, G-TL, & Cornell Media

Phase 4

Withdrawn

Conditions: Infertility

Interventions: Biological: Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media

First Posted Date: 2018-09-27

Last Posted Date: 2018-09-27

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT03687697

Locations: 🇺🇸
Center for Reproductive Medicine, New York, New York, United States

The Comparative Effectiveness Dementia & Alzheimer's Registry

Conditions: Mild Cognitive Impairment
Alzheimer Disease

First Posted Date: 2018-09-27

Last Posted Date: 2025-04-30

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 452

Registration Number: NCT03687710

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Phase 2

Terminated

Conditions: Waldenstrom Macroglobulinemia
Waldenstrom's Disease
Waldenström; Hypergammaglobulinemia
Waldenstrom's Macroglobulinemia Refractory
Waldenstrom's Macroglobulinemia Recurrent
Waldenstrom's Macroglobulinemia of Lymph Nodes
Waldenstrom's Macroglobulinaemia, Without Mention of Remission

Interventions: Drug: Ibrutinib
Drug: Daratumumab

First Posted Date: 2018-09-20

Last Posted Date: 2023-10-23

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 1

Registration Number: NCT03679624

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

PSMA Imaging of Localized Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: 89ZR-DF-IAB2M
Drug: 68Ga-PSMA-HBED-CC

First Posted Date: 2018-09-18

Last Posted Date: 2020-10-14

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT03675451

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

Phase 1

Completed

Conditions: REM Sleep Behavior Disorder
Healthy
Parkinson Disease

Interventions: Drug: (11C)PE2I
Drug: Ioflupane

First Posted Date: 2018-09-18

Last Posted Date: 2025-03-12

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 82

Registration Number: NCT03675282

Locations: 🇺🇸
Hospital for Special Surgery, New York, New York, United States

PET Measures of CSF Clearance in Preclinical Alzheimer's Disease

Completed

Conditions: Mild Cognitive Impairment

First Posted Date: 2018-09-10

Last Posted Date: 2022-10-20

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 116

Registration Number: NCT03663387

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy